To facilitate peer support and education for individuals with chronic pain and their families so that these individuals may live more fully in spite of their pain.
To raise awareness among the health care community, policy makers, and the public at large about issues of living with chronic pain.
FDA Extends REMS Comment Period to October 19, 2010
The Food and Drug Administration is now developing Risk Evaluation and Mitigation Strategies (REMS) for certain opioid drugs. They are intended to ensure that the benefits of these drugs continue to outweigh certain risks and may include limits on prescribing and dispensing them as well as education about the risks.
As a person with an interest in pain and its management, you have a right to take part in the discussion that will lead to the final REMS for opioid medications.
Development of this new ACPA web site was
made possible through an unrestricted
educational grant from Purdue Pharma.
Purdue has no influence on the editorial content of the site. Ongoing funding also comes from memberships/donations from a range of individual contributors.